CD276 and preeclampsia: Thus, our findings support the hypothesis of immune maladaptation in preeclampsia, where diminished expression of tolerogenic molecules, such as B7-H3, leads to uncontrolled effector immune responses, ultimately contributing to shallow placentation and maternal endothelial dysfunction.